In this special edition of the weekly dose podcast, Dave knapp covers the recent fourth-quarter earnings call from Novo Nordisk. What does this mean for users of Ozempic Wegovy??  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMPeptideVite GLP-1 Suppliment: Https://www.zennutrients.com/mounjaroman10% OFF CODE: DAVIDKZepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPFollow My Switch To Ozempic Chronologically: https://www.youtube.com/playlist?list=PLtOcNl0C8quXRPsuP6u5O5l4LuCWFHKNce#elililly #novonordisk #ozempic #wegovy #zepbound #onthepen #manonthemounjaro #semaglutide #liraglutide #saxenda #victoza #obesitymedicine #elililly #novonordisk #diabetes #diabesity #trulicityThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!